Landscape Capital Management L.L.C. Buys New Holdings in Indivior PLC (NASDAQ:INDV)

Landscape Capital Management L.L.C. purchased a new position in Indivior PLC (NASDAQ:INDV) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 78,682 shares of the company’s stock, valued at approximately $978,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Indivior during the fourth quarter worth $56,000. Stifel Financial Corp purchased a new stake in Indivior in the 3rd quarter worth $100,000. Jane Street Group LLC bought a new position in shares of Indivior during the 3rd quarter valued at about $180,000. Public Employees Retirement System of Ohio purchased a new position in shares of Indivior during the third quarter valued at about $294,000. Finally, China Universal Asset Management Co. Ltd. bought a new stake in shares of Indivior in the fourth quarter worth about $359,000. 60.33% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

INDV has been the subject of several research analyst reports. Rodman & Renshaw initiated coverage on Indivior in a report on Tuesday, January 28th. They set a “buy” rating and a $16.00 price target for the company. RODMAN&RENSHAW raised shares of Indivior to a “strong-buy” rating in a research note on Tuesday, January 28th. Finally, Piper Sandler cut their target price on Indivior from $16.00 to $13.00 and set an “overweight” rating on the stock in a research report on Thursday, March 6th.

Indivior Trading Down 2.5 %

NASDAQ:INDV opened at $9.15 on Friday. The stock has a fifty day simple moving average of $9.98 and a 200-day simple moving average of $10.37. The company has a market cap of $1.26 billion, a price-to-earnings ratio of -26.14 and a beta of 0.93. Indivior PLC has a twelve month low of $7.33 and a twelve month high of $21.64.

Indivior (NASDAQ:INDV) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.32 EPS for the quarter, meeting the consensus estimate of $0.32. The business had revenue of $298.00 million during the quarter, compared to analyst estimates of $262.35 million. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. As a group, equities research analysts predict that Indivior PLC will post 1.22 EPS for the current fiscal year.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.